Emergent BioSolutions (EBS) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free EBS Stock Alerts $6.19 -0.07 (-1.12%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 6:40 AM | americanbankingnews.comEmergent BioSolutions Inc. (NYSE:EBS) Director Sells $61,100.00 in StockJune 8 at 1:26 AM | americanbankingnews.comTraders Buy Large Volume of Put Options on Emergent BioSolutions (NYSE:EBS)June 7 at 8:40 AM | insidertrades.comKathryn C. Zoon Sells 10,000 Shares of Emergent BioSolutions Inc. (NYSE:EBS) StockJune 6, 2024 | marketbeat.comInsider Selling: Emergent BioSolutions Inc. (NYSE:EBS) Director Sells 10,000 Shares of StockEmergent BioSolutions Inc. (NYSE:EBS - Get Free Report) Director Kathryn C. Zoon sold 10,000 shares of the stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $6.11, for a total transaction of $61,100.00. Following the completion of the transaction, the director now owns 54,482 shares of the company's stock, valued at approximately $332,885.02. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.June 6, 2024 | marketbeat.comEmergent BioSolutions Sees Unusually High Options Volume (NYSE:EBS)Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock traders purchased 5,129 put options on the company. This is an increase of approximately 305% compared to the average volume of 1,265 put options.June 6, 2024 | globenewswire.comEmergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness DayJune 3, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $6.90 Million Holdings in Emergent BioSolutions Inc. (NYSE:EBS)Charles Schwab Investment Management Inc. boosted its position in shares of Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,873,984 shares of the biopharmaceuticMay 21, 2024 | investorplace.com7 Stocks to Buy Immediately Following Strong EarningsMay 16, 2024 | investorplace.comVice Stock Vanguards: 3 Sin Stocks Delivering Heavenly ReturnsMay 10, 2024 | globenewswire.comEmergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024May 2, 2024 | msn.comEmergent BioSolutions gains as results top estimates, co to cut 300 jobsMay 2, 2024 | msn.comEmergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?May 2, 2024 | bizjournals.comWhy this Gaithersburg biotech's stock is surgingMay 2, 2024 | finance.yahoo.comQ1 2024 Emergent BioSolutions Inc Earnings CallMay 2, 2024 | investorplace.comEmergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job CutsMay 2, 2024 | finance.yahoo.comEmergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...May 2, 2024 | investorplace.comWhy Is Emergent BioSolutions (EBS) Stock Up 57% Today?May 2, 2024 | investorplace.comEBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | bizjournals.comGaithersburg biotech to shutter Baltimore facility amid cost-cuttingMay 1, 2024 | bizjournals.comEmergent BioSolutions eliminating 300 jobs, shutting down multiple facilitiesMay 1, 2024 | finance.yahoo.comNarcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close FacilitiesMay 1, 2024 | finance.yahoo.comEmergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...May 1, 2024 | globenewswire.comEmergent BioSolutions Reports First Quarter 2024 Financial ResultsMay 1, 2024 | reuters.comEmergent BioSolutions to lay off about 300 employeesMay 1, 2024 | globenewswire.comEmergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionMay 1, 2024 | globenewswire.comEmergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneMay 1, 2024 | markets.businessinsider.comEmergent BioSolutions earnings: here's what Wall Street expectsApril 30, 2024 | bizjournals.comEmergent BioSolutions doling out big bonuses to retain top execsApril 30, 2024 | globenewswire.comEmergent BioSolutions Announces Amendment to its Existing Credit FacilityApril 24, 2024 | msn.comFDA approves Amneal's generic version of OTC NarcanApril 24, 2024 | marketbeat.comEmergent BioSolutions (EBS) to Release Earnings on WednesdayEmergent BioSolutions (NYSE:EBS) will be releasing earnings after the market closes on Wednesday, May 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587152)April 22, 2024 | globenewswire.comEmergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024April 17, 2024 | finance.yahoo.comInstitutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year lossesApril 14, 2024 | marketbeat.comShort Interest in Emergent BioSolutions Inc. (NYSE:EBS) Expands By 16.1%Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,700,000 shares, a growth of 16.1% from the March 15th total of 4,910,000 shares. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is currently 1.9 days. Currently, 11.4% of the shares of the stock are short sold.April 11, 2024 | marketbeat.comEmergent BioSolutions' (EBS) Buy Rating Reiterated at BenchmarkBenchmark reiterated a "buy" rating and set a $5.00 price target on shares of Emergent BioSolutions in a report on Thursday.April 5, 2024 | marketbeat.comAssenagon Asset Management S.A. Acquires 651,480 Shares of Emergent BioSolutions Inc. (NYSE:EBS)Assenagon Asset Management S.A. lifted its holdings in shares of Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 356.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 834,372 shares of the biopharmaceutical company's stockApril 1, 2024 | finance.yahoo.comAquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveMarch 30, 2024 | marketbeat.comEmergent BioSolutions Inc. (NYSE:EBS) Short Interest Down 20.8% in MarchEmergent BioSolutions Inc. (NYSE:EBS - Get Free Report) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,910,000 shares, a decrease of 20.8% from the February 29th total of 6,200,000 shares. Based on an average daily volume of 3,000,000 shares, the short-interest ratio is presently 1.6 days. Approximately 9.8% of the shares of the company are sold short.March 28, 2024 | globenewswire.comEmergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisMarch 27, 2024 | bizjournals.comWhy this Maryland biotech furloughed 130 workers in MichiganMarch 25, 2024 | globenewswire.comEmergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityMarch 12, 2024 | marketwatch.comEmergent BioSolutions Shares Drop on S&P DowngradeMarch 7, 2024 | realmoney.thestreet.comBenchmark gets more bullish on Emergent BioSolutions, upgrades sharesMarch 7, 2024 | realmoney.thestreet.comEmergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 reportMarch 7, 2024 | finance.yahoo.comEmergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial ResultsMarch 7, 2024 | finance.yahoo.comEmergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | marketbeat.comEmergent BioSolutions (NYSE:EBS) Lifted to Buy at BenchmarkBenchmark upgraded shares of Emergent BioSolutions from a "hold" rating to a "buy" rating and set a $5.00 target price on the stock in a report on Thursday.March 7, 2024 | finance.yahoo.comQ4 2023 Emergent BioSolutions Inc Earnings CallMarch 7, 2024 | fool.comEmergent BioSolutions (EBS) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | investorplace.comEBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023 Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. EBS Media Mentions By Week EBS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EBS News Sentiment▼0.750.76▲Average Medical News Sentiment EBS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EBS Articles This Week▼82▲EBS Articles Average Week Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MNKD News INVA News IRWD News OPK News LXRX News VNDA News AGEN News XOMA News CDXS News ACHV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EBS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored